Rapport Therapeutics (RAPP)
Rapport Therapeutics (RAPP) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- RAPP last traded at $24.59, -1.82% on the day.
- Rapport Therapeutics: P/E -8.1.
- Over the past year RAPP returned -8.50%; year to date -18.94%.
Updated 2026-11-02 19:07 UTC